$176.43
1.500.86%
At close: Jun 22, 5:00 PM EST
$181.50
5.072.87%
After Hours: 4:42 PM EST
AstraZeneca PLC Analyst Ratings
AZNNYSE
AstraZeneca Analyst Ratings and Price Targets | NYSE:AZN | Benzinga
AstraZeneca PLC has a consensus price target of $88.8 based on the ratings of 12 analysts. The high is $97 issued by Goldman Sachs on May 30, 2024. The low is $82 issued by BMO Capital on April 26, 2024. The 3 most-recent analyst ratings were released by TD Cowen, Argus Research, and Goldman Sachs on August 12, 2024, May 30, 2024, and May 30, 2024, respectively. With an average price target of $92.33 between TD Cowen, Argus Research, and Goldman Sachs, there's an implied -49.13% downside for AstraZeneca PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
TD Cowen
Argus Research
Goldman Sachs
BMO Capital
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for AstraZeneca
Loading calendar...
FAQ
What is the target price for AstraZeneca (AZN) stock?
The latest price target for AstraZeneca (NYSE:AZN) was reported by Jefferies on October 27, 2025. The analyst firm set a price target for $0.00 expecting AZN to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for AstraZeneca (AZN)?
The latest analyst rating for AstraZeneca (NYSE:AZN) was provided by Jefferies, and AstraZeneca their buy rating.
When was the last upgrade for AstraZeneca (AZN)?
The last upgrade for AstraZeneca PLC happened on February 13, 2025 when UBS raised their price target to N/A. UBS previously had a neutral for AstraZeneca PLC.
When was the last downgrade for AstraZeneca (AZN)?
The last downgrade for AstraZeneca PLC happened on February 8, 2024 when Deutsche Bank changed their price target from N/A to N/A for AstraZeneca PLC.
When is the next analyst rating going to be posted or updated for AstraZeneca (AZN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AstraZeneca, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AstraZeneca was filed on October 27, 2025 so you should expect the next rating to be made available sometime around October 27, 2026.
Is the Analyst Rating AstraZeneca (AZN) correct?
While ratings are subjective and will change, the latest AstraZeneca (AZN) rating was a with a price target of $0.00 to $0.00. The current price AstraZeneca (AZN) is trading at is $181.50, which is out of the analyst’s predicted range.
